Evolving rare B cell lineages for an effective HIV vaccine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40743359.
- Also identified by DOI 10.1126/science.adz6436 and PMC identifier 12951596.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clinical trials show that strategies to elicit the production of broadly neutralizing antibodies have a promising start.
Medical subject headings
- AIDS Vaccines
- B-Lymphocytes
- Broadly Neutralizing Antibodies
- HIV Antibodies
- HIV Infections
- HIV-1